BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Living in the dark: Gaza’s struggle for electricity - 2Italy Brings In New Measures In 2026 To Tackle Overtourism
- 3Understanding Successful Compromise Standards to Cultivate Agreeable Connections
- 4Heart disease risk greater for women with a common condition they may not be aware they have
- 5Flu cases are rising with a strain that makes older people sicker
- Material of Innovativeness: A Survey of \Releasing Your Imaginative Potential\ Online Workmanship Course
- Supportive Tips On Home loans For First-Time Home Purchasers
- FDA updates risk classification for voluntary shredded cheese recall
- Physicists and philosophers have long struggled to understand the nature of time: Here's why
- When a sperm whale gives birth, the mother gets help from her friends
- Tech for Efficiency: Applications and Apparatuses to Accomplish More
- Fundamental Venture The board Apparatuses for Remote Groups
- Don't plan to cook on Thanksgiving? Here are the restaurants and fast food places that are scheduled to be open
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
